FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39934811000001107: Bimekizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Aug 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1978371000001111 Bimekizumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1978381000001113 Bimekizumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bimekizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Bimekizumab 160mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Bimekizumab Inferred relationship Existential restriction modifier
Bimekizumab 160mg/1ml solution for injection pre-filled syringes Has specific active ingredient True Bimekizumab Inferred relationship Existential restriction modifier
Bimzelx 160mg/1ml solution for injection pre-filled pens (UCB Pharma Ltd) Has specific active ingredient True Bimekizumab Inferred relationship Existential restriction modifier
Bimekizumab 160mg/1ml solution for injection pre-filled disposable devices 2 pre-filled disposable injection Has specific active ingredient True Bimekizumab Inferred relationship Existential restriction modifier
Bimzelx 160mg/1ml solution for injection pre-filled syringes (UCB Pharma Ltd) Has specific active ingredient True Bimekizumab Inferred relationship Existential restriction modifier
Bimzelx 160mg/1ml solution for injection pre-filled pens (UCB Pharma Ltd) 2 pre-filled disposable injection Has specific active ingredient True Bimekizumab Inferred relationship Existential restriction modifier
Bimzelx 160mg/1ml solution for injection pre-filled syringes (UCB Pharma Ltd) 2 pre-filled disposable injection Has specific active ingredient True Bimekizumab Inferred relationship Existential restriction modifier
Bimekizumab 160mg/1ml solution for injection pre-filled syringes 2 pre-filled disposable injection Has specific active ingredient True Bimekizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start